The Commission has authorised Abrysvo, the first vaccine to protect older adults and infants up to six months of age against the lower respiratory tract disease caused by the respiratory syncytial virus (RSV). This type of vaccines is particularly important bearing in mind the increased RSV infections in the EU last winter. The vaccine, which […]